Approval · Notice of Compliance 1081 · 2000
ORGARAN: Notice of Compliance 1081
Issued December 5, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1081
- Date
- December 5, 2000
- Company
- Organon Canada Inc.Kirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Priority
- Reason
- New indication for heparin-induced thrombocytopenia (hit)
- Therapeutic class
- Anticoagulant/antithrombotic agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ORGARAN | Not yet assigned | — |
Medicinal ingredients
- DANAPAROID SODIUM 750 UNIT per AMP